Downstream Processing Featured Articles

  1. FDA Lifts Clinical Hold On Lpath's iSONEP 8/27/2012

    Lpath, Inc. (OTCQB: LPTN), the industry leader in bioactive lipid-targeted therapeutics, reported that the FDA has lifted the clinical hold on iSONEP™, Lpath's anti-S1P monoclonal antibody that is being developed as a potential treatment for wet AMD and possibly other ocular disorders.

  2. Sunshine Biopharma Initiates IND-Enabling Studies For Its Anticancer Compound, Adva-27a 11/13/2012

    Sunshine Biopharma Inc. (OTCBB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has initiated the IND-Enabling studies for Adva-27a, the Company's flagship oncology drug candidate.

  3. Lonza And OncoMed Pharmaceuticals Sign A Process Development And Manufacturing Collaboration And Multi-Product GS License Agreement For Anti-Cancer Therapeutics 10/23/2012

    Lonza, a global leader in biological manufacturing and OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced recently an agreement for the development and manufacture of OncoMed’s pipeline of anti-cancer stem cell therapeutics.

  4. The Benefits Of Genderless Sterile Connectors For Single-Use Applications

    Genderless connections are those in which the connector halves are identical in design, thus eliminating the need for different male and female halves to make the connection.

  5. Scientists Find A New Way To Boost Common Cancer Drugs 1/14/2013

    Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue of Cancer Discovery.

  6. Pfenex Inc. Awards Althea Technologies A Contract For cGMP Manufacturing Of Circumsporozoite Protein From Plasmodium Falciparum, A Key Malaria Antigen 10/24/2012

    Pfenex Inc. recently announced that it has awarded Althea Technologies a contract for the current Good Manufacturing Practice (cGMP) manufacturing of circumsporozoite protein (CSP) from Plasmodium falciparum, an important and proven component of an effective malaria vaccine.

  7. NIH-Funded Researchers Create Next-Generation Alzheimer's Disease Model 4/9/2013

    A new genetically engineered lab rat that has the full array of brain changes associated with Alzheimer’s disease supports the idea that increases in a molecule called beta-amyloid in the brain causes the disease, according to a study, published in the Journal of Neuroscience.

  8. Ablynx And Its Partner Advance Nanobody Candidate ALX-0751 In Pre-Clinical Development 9/20/2012

    Ablynx [Euronext Brussels: ABLX] today announced that they have advanced the Nanobody(®) candidate ALX-0751, together with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, into pre-clinical development in the field of oncology. 

  9. Saint-Gobain Adds Large Clamps To Pure-Fit® Line 6/28/2012

    New Pure-Fit® TCL accommodates large diameter and thick wall tubing applications. Saint-Gobain Performance Plastics has expanded its line of innovative tube clamps with the introduction of the new Pure-Fit® TCL large tube clamp.

  10. Stellar Biotechnologies Announces Filing A US Letters Patent Application 10/4/2012

    Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT) is very pleased to announce the filing of a US Letters Patent Application directed to protecting certain proprietary KLH manufacturing controls, KLH formulations and kits used in immunotoxicology and immune status testing which were invented by Drs. Chow, Sundsmo and Sagermann.